NCT05389514 2025-11-20
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors
Providence Health & Services
Temporarily not available
Clinical Trials
1 trialsExpanded_access × KRAS G12V Mutant Advanced Epithelial Cancers × Insulin Infusion Systems × Clear all